Business Club March 2nd News China is the world's largest producer of vitamins, China's production of vitamin products all varieties, large production, advanced technology, in the world vitamin industry occupies a decisive position, the main advantages of vitamin C, vitamin E, Vitamin A and B vitamins are also export-oriented products. In 2010, the export volume of vitamin products was 195,000 tons, an increase of 33.5% year-on-year, and the export value was 2.3 billion US dollars, a year-on-year increase of 11.3%. The export shows the following characteristics:
First, the number of exports has increased substantially, the export prices of large varieties have decreased, and the export prices of small varieties have risen. In 2010, the export volume of vitamin products increased by 33.5%, and the average export price decreased by 16.6% year-on-year. This is the fourth consecutive boom year for vitamin products. After the first decline, the drop was significant and it was also rare in the entire API. The main reason is that prices of vitamin C and vitamin E have fallen due to the two pillar products. In 2010, the export volume of vitamin C increased by 46.8%, the unit price of export decreased by 31.3%, the export volume of vitamin E increased by 30.6%, and the unit price of export decreased by 3.3%.
To mention vitamin C, it should be said that it is not only the pride of China's vitamin export industry, but also the pride of China's entire pharmaceutical export industry. At present, the global vitamin C production plant is concentrated in China except for the DSM Scotland factory. The vast majority of vitamin C produced in China is used for export, accounting for 90% of the international market share, and this part of the market demand for rigidity, demand increases year by year. At the end of 2008, when the US subprime mortgage crisis triggered a global economic downturn, which also had a huge impact on China's exports, Vitamin C exports thrived, export value doubled, export prices increased by 82%, and the vitamin C industry entered a period of high prosperity, and Continue until the full year of 2009.
As a result, the expansion of redevelopment projects around the country has led to rapid expansion of production capacity. According to the investigation of vitamin C industry released by the National Development and Reform Commission and the Ministry of Industry and Information Technology, due to the violation of regulations in some localities and the construction of new vitamin C capacity projects, China's vitamin C industry has a serious overcapacity and will exceed the global demand by nearly one time. The total capacity of vitamin C that has been built, under construction, and planned is more than 80,000 tons. It is expected that the capacity of vitamin C will be close to 180,000 tons by the end of 2010, and will exceed 200,000 tons in 2012, while the global vitamin C market demand is only about 120,000 tons. . In view of this, in 2010, when the pharmaceutical industry experienced an upsurge of volume and price, the export performance of vitamin C products was very different. The reason for the continuous decline in export prices was clear.
In contrast, vitamin E conditions are much better. Vitamin E ranks second in the export of vitamins. The major domestic manufacturers are Zhejiang Pharmaceuticals Co., Ltd. and Zhejiang Xinsuo, which account for 40% of the international market share. Due to the difficulty of vitamin E technology, the number of synthetic reaction steps, the limitation of intermediate channels, and the high barriers to entry for industries such as large capital investment, therefore, although the degree of prosperity is of the same concern as vitamin C, it is still not available. With new competitors entering the industry, the degree of industrial concentration is relatively high and the market supply and demand are basically balanced.
In addition, export prices of some small varieties, such as vitamin B12 and vitamin B2, have risen to different levels, at 96.3% and 8.5%, respectively. What needs further explanation is vitamin B12. According to customs statistics, total exports fell by 34.2% in 2010, mainly due to a significant reduction in the number of feed-grade B12 exports, a year-on-year decrease of 45.4%, and an export price of US$27.7/kg, a year-on-year increase of 100.2%. The export volume of cyanocobalamin and its derivatives still increased by 21%, and the export price was 2817.7 USD/kg, an increase of 7% year-on-year.
Second, exports to the mainstream market is still Europe and the United States and Asia In 2010, China's vitamin products exported to 132 countries and regions, compared to last year increased eight emerging markets. The EU, North America and Asia remain the major markets for my exports, with a share of 90.2%. My number of exports to the three major markets increased by more than 27% year-on-year, with 39.2% for the EU, 27.4% for North America, and 27.8% for Asia. In terms of market demand, Asian market demand has maintained a sustained growth for more than ten years, and the export amount has increased by 1.3% compared with last year. After the negative growth of the EU and North America markets in 2009, the number of exports rebounded significantly. At the same time, the export volume of these two markets accounted for 1.1% and 0.1%, respectively, compared with last year, indicating that market demand is recovering.
The top ten destination countries for exporting vitamin products in 2010 were the United States, Germany, the Netherlands, Japan, Belgium, India, South Korea, Brazil, Thailand, and Singapore. Compared with 2009, the order rankings were slightly different. In 2010, China’s exports to the above-mentioned ten countries all increased in different degrees, with the largest increases being Germany, India, and Thailand, with growth rates of 59.4%, 42.3%, and 45.3%, respectively. The smaller relative increase was Japan, but the magnitude It is also above 13%. This fully shows that the market pattern of vitamin products has not changed and the demand in the mainstream market remains strong.
Emerging markets Chile, Russia, and Chile have enjoyed good growth, with export growth above 100%.
The increase in export prices relative to the quantity is a clear downward trend. The price drop was less in the Netherlands and Singapore, only 3 percentage points, and the larger declines were in Germany, Japan and Brazil, both above 20%.
Third, the industrial concentration is high, and the industrial chain is complete. The proportion of exports from the top ten companies accounts for 60%. At present, vitamin companies in China have achieved production technology advantages and international competitive advantages in several vitamin market segments. Basically, several companies The single vitamin varieties account for most of the global market share, and the industry concentration is very high.
In 2010, Hangzhou Xinfu Pharmaceutical Co., Ltd.'s share of vitamin B5 exports was as high as 72.6%. Hubei Guangji Pharmaceutical Co., Ltd. also exported more than 70% of vitamin B2. The proportion of the top ten companies in the export volume of other single vitamin products was also between 86% and 96%.
In 2010, there were 827 exporters of vitamin products, Zhejiang Pharmaceutical Co., Ltd., Shiyao Group, Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd., Zhejiang Xinhecheng Co., Ltd., Northeast Pharmaceutical Group Co., Ltd., Zibo Luwei Foods. Biological Co., Ltd., North China Pharmaceutical Co., Ltd., Jiangsu Jiangshan Pharmaceutical Co., Ltd., Zhejiang Xinweipu Additives Co., Ltd., Shanghai Waigaoqiao Bonded Logistics Park Service Trade Co., Ltd., DSM Vitamins (Shanghai) Co., Ltd., etc. Ten. The sum of the export amount of the above ten enterprises accounted for 63.4% of the total export volume of vitamin products in China.
In terms of the nature of export enterprises, the export value of state-owned enterprises, foreign-funded enterprises and private enterprises accounted for 37.6%, 35% and 27.3%, respectively. Among the top ten companies, there are 4 state-owned enterprises, 5 foreign-funded enterprises and 1 private enterprise.
As we all know, vitamin products are widely used in medicine, food additives, feed additives and other fields, and with the improvement of people's living standards and changes in diet structure shows the trend of increasing market demand. The market demand for vitamins mainly comes from the downstream industries such as feed, food, medicine and cosmetology, with an increase of approximately 5% per year. Although the demand for the vitamin market has always been good, the capacity is still limited. With the current situation of domestic raw material medicines, rare varieties are truly in short supply, and most of the products will be quickly supplemented even if short supply is caused due to insufficient supply from manufacturers. In 2010, Vitamin C encountered Waterloo is a good example. When the new production capacity has not yet been truly produced, a series of expansion and production information has caused the market to suffer a slump. It can be said that overcapacity has caused low-price competition among domestic enterprises and has always plagued all raw material drug exporters, including vitamins. Domestic APIs are usually long-lasting in the bottom of the valley. Occasionally, the peaks of the peaks are difficult to last, forming a vicious circle. According to statistics, at present, China’s overall exports are approaching the critical line, and the space for the export price competitiveness of China’s exports has been limited. Fortunately, the relevant government departments have begun to intensify their efforts to carry out the work of eliminating excess production capacity.
Looking ahead to the 2011 vitamin market, it will be affected by changes in the international market, product industry concentration, national policies and regulations, and how dynamic trends will become the focus of attention in the industry.
First, the number of exports has increased substantially, the export prices of large varieties have decreased, and the export prices of small varieties have risen. In 2010, the export volume of vitamin products increased by 33.5%, and the average export price decreased by 16.6% year-on-year. This is the fourth consecutive boom year for vitamin products. After the first decline, the drop was significant and it was also rare in the entire API. The main reason is that prices of vitamin C and vitamin E have fallen due to the two pillar products. In 2010, the export volume of vitamin C increased by 46.8%, the unit price of export decreased by 31.3%, the export volume of vitamin E increased by 30.6%, and the unit price of export decreased by 3.3%.
To mention vitamin C, it should be said that it is not only the pride of China's vitamin export industry, but also the pride of China's entire pharmaceutical export industry. At present, the global vitamin C production plant is concentrated in China except for the DSM Scotland factory. The vast majority of vitamin C produced in China is used for export, accounting for 90% of the international market share, and this part of the market demand for rigidity, demand increases year by year. At the end of 2008, when the US subprime mortgage crisis triggered a global economic downturn, which also had a huge impact on China's exports, Vitamin C exports thrived, export value doubled, export prices increased by 82%, and the vitamin C industry entered a period of high prosperity, and Continue until the full year of 2009.
As a result, the expansion of redevelopment projects around the country has led to rapid expansion of production capacity. According to the investigation of vitamin C industry released by the National Development and Reform Commission and the Ministry of Industry and Information Technology, due to the violation of regulations in some localities and the construction of new vitamin C capacity projects, China's vitamin C industry has a serious overcapacity and will exceed the global demand by nearly one time. The total capacity of vitamin C that has been built, under construction, and planned is more than 80,000 tons. It is expected that the capacity of vitamin C will be close to 180,000 tons by the end of 2010, and will exceed 200,000 tons in 2012, while the global vitamin C market demand is only about 120,000 tons. . In view of this, in 2010, when the pharmaceutical industry experienced an upsurge of volume and price, the export performance of vitamin C products was very different. The reason for the continuous decline in export prices was clear.
In contrast, vitamin E conditions are much better. Vitamin E ranks second in the export of vitamins. The major domestic manufacturers are Zhejiang Pharmaceuticals Co., Ltd. and Zhejiang Xinsuo, which account for 40% of the international market share. Due to the difficulty of vitamin E technology, the number of synthetic reaction steps, the limitation of intermediate channels, and the high barriers to entry for industries such as large capital investment, therefore, although the degree of prosperity is of the same concern as vitamin C, it is still not available. With new competitors entering the industry, the degree of industrial concentration is relatively high and the market supply and demand are basically balanced.
In addition, export prices of some small varieties, such as vitamin B12 and vitamin B2, have risen to different levels, at 96.3% and 8.5%, respectively. What needs further explanation is vitamin B12. According to customs statistics, total exports fell by 34.2% in 2010, mainly due to a significant reduction in the number of feed-grade B12 exports, a year-on-year decrease of 45.4%, and an export price of US$27.7/kg, a year-on-year increase of 100.2%. The export volume of cyanocobalamin and its derivatives still increased by 21%, and the export price was 2817.7 USD/kg, an increase of 7% year-on-year.
Second, exports to the mainstream market is still Europe and the United States and Asia In 2010, China's vitamin products exported to 132 countries and regions, compared to last year increased eight emerging markets. The EU, North America and Asia remain the major markets for my exports, with a share of 90.2%. My number of exports to the three major markets increased by more than 27% year-on-year, with 39.2% for the EU, 27.4% for North America, and 27.8% for Asia. In terms of market demand, Asian market demand has maintained a sustained growth for more than ten years, and the export amount has increased by 1.3% compared with last year. After the negative growth of the EU and North America markets in 2009, the number of exports rebounded significantly. At the same time, the export volume of these two markets accounted for 1.1% and 0.1%, respectively, compared with last year, indicating that market demand is recovering.
The top ten destination countries for exporting vitamin products in 2010 were the United States, Germany, the Netherlands, Japan, Belgium, India, South Korea, Brazil, Thailand, and Singapore. Compared with 2009, the order rankings were slightly different. In 2010, China’s exports to the above-mentioned ten countries all increased in different degrees, with the largest increases being Germany, India, and Thailand, with growth rates of 59.4%, 42.3%, and 45.3%, respectively. The smaller relative increase was Japan, but the magnitude It is also above 13%. This fully shows that the market pattern of vitamin products has not changed and the demand in the mainstream market remains strong.
Emerging markets Chile, Russia, and Chile have enjoyed good growth, with export growth above 100%.
The increase in export prices relative to the quantity is a clear downward trend. The price drop was less in the Netherlands and Singapore, only 3 percentage points, and the larger declines were in Germany, Japan and Brazil, both above 20%.
Third, the industrial concentration is high, and the industrial chain is complete. The proportion of exports from the top ten companies accounts for 60%. At present, vitamin companies in China have achieved production technology advantages and international competitive advantages in several vitamin market segments. Basically, several companies The single vitamin varieties account for most of the global market share, and the industry concentration is very high.
In 2010, Hangzhou Xinfu Pharmaceutical Co., Ltd.'s share of vitamin B5 exports was as high as 72.6%. Hubei Guangji Pharmaceutical Co., Ltd. also exported more than 70% of vitamin B2. The proportion of the top ten companies in the export volume of other single vitamin products was also between 86% and 96%.
In 2010, there were 827 exporters of vitamin products, Zhejiang Pharmaceutical Co., Ltd., Shiyao Group, Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd., Zhejiang Xinhecheng Co., Ltd., Northeast Pharmaceutical Group Co., Ltd., Zibo Luwei Foods. Biological Co., Ltd., North China Pharmaceutical Co., Ltd., Jiangsu Jiangshan Pharmaceutical Co., Ltd., Zhejiang Xinweipu Additives Co., Ltd., Shanghai Waigaoqiao Bonded Logistics Park Service Trade Co., Ltd., DSM Vitamins (Shanghai) Co., Ltd., etc. Ten. The sum of the export amount of the above ten enterprises accounted for 63.4% of the total export volume of vitamin products in China.
In terms of the nature of export enterprises, the export value of state-owned enterprises, foreign-funded enterprises and private enterprises accounted for 37.6%, 35% and 27.3%, respectively. Among the top ten companies, there are 4 state-owned enterprises, 5 foreign-funded enterprises and 1 private enterprise.
As we all know, vitamin products are widely used in medicine, food additives, feed additives and other fields, and with the improvement of people's living standards and changes in diet structure shows the trend of increasing market demand. The market demand for vitamins mainly comes from the downstream industries such as feed, food, medicine and cosmetology, with an increase of approximately 5% per year. Although the demand for the vitamin market has always been good, the capacity is still limited. With the current situation of domestic raw material medicines, rare varieties are truly in short supply, and most of the products will be quickly supplemented even if short supply is caused due to insufficient supply from manufacturers. In 2010, Vitamin C encountered Waterloo is a good example. When the new production capacity has not yet been truly produced, a series of expansion and production information has caused the market to suffer a slump. It can be said that overcapacity has caused low-price competition among domestic enterprises and has always plagued all raw material drug exporters, including vitamins. Domestic APIs are usually long-lasting in the bottom of the valley. Occasionally, the peaks of the peaks are difficult to last, forming a vicious circle. According to statistics, at present, China’s overall exports are approaching the critical line, and the space for the export price competitiveness of China’s exports has been limited. Fortunately, the relevant government departments have begun to intensify their efforts to carry out the work of eliminating excess production capacity.
Looking ahead to the 2011 vitamin market, it will be affected by changes in the international market, product industry concentration, national policies and regulations, and how dynamic trends will become the focus of attention in the industry.
Gelatin Capsule,Turmeric Capsule,Silybum Marianum Capsule,Curcuma Longa Root Capsule
Weihai Baihe Biology Technological Co., Ltd. , https://www.biohighnutraceutical.com